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The expression of the a6fJ4 and a6fJl integrins on epidermal 
Langerhans cells (LC) before and after mast cell degranula-
tion was studied in cultured human neonatal foreskin by 
immunohistochemistry. Twenty-four hours after addition of 
mast cell secretagogues, morphine sulfate, or substance P, 
solitary mid-epidermal cells showed staining for the integrin 
subunits a6, fJ4, and fJl. This expression was not observed in 
cultured control explants, and immunostained cells were 
confirmed to be non-epithelial, dendritic cells by immuno-
electron microscopy. The identity of these cells as LC was 
further established by coincident staining for a6 and CD la 
using double immunofluorescence labeling. Addition of 
tumor necrosis factor-a (TNFa), the predominant cytokine 
L angerhans cells (LC) are well recognized as central com-ponents of skin-associated lymphoid tissues [1]. The ability of LC to function as antigen-presenting cells is crucial to their role in contact hypersensitivity [2]. However, differences have been shown to exist between 
LC that present antigen to naive versus previously sensitized mem-
ory/effector T lymphocytes [2]. Although sensitization of naive T 
lymphocytes to antigen presented by LC occurs in the lymph node, 
antigen presentation to memory/effector T lymphocytes most 
likely occurs in the epidermis, the site where inflammation ensues 
after antigenic challenge [2]. Accordingly, LC during sensitization 
must be motile, whereas during chall enge many appear to be an-
chored within the epidermis. A mechanism for this dichotomy has 
yet to be elucidated, although studies have proposed that tumor 
necrosis factor (TN Fa) may play an important, but undefined, role 
[3] . In mice, for example, intradermal injections of TN Fa blocked 
the induction of contact hypersensitivity to immunogenic doses of 
hapten subsequently applied to the site of injection, and the systemic 
administration of neutralizing anti-TNFO' antibodies prevented in -
tradermal TNFO'-induced abrogation of contact hypersensitivity 
[4]. These effects have been hypothesized to relate to the potential 
ability of TN Fa to affect localization or mobility of LC within the 
epidermis [4]. 
In addition to keratinocytes [4] and monocytes/macrophages, a 
second important source of cutaneous TNFO' has been recently 
identified in dermal mast cells [5]. Functionally, early preclinical 
events in delayed hypersensitivity chall enge reactions involve mast 
cell degranulation and rapid induction of certain endothelial-leuko-
cyte adhesion molecules through the release of mast cell- derived 
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in mast cell granules, also induced LC to express a6 integrins. 
Furthermore, preincubation of skin organ cultures with anti-
TNFa antibodies or the mast cell inhibitor cromolyn sodium 
abrogated the ability to induce a6 integrins on LC conse-
quent to experimental m.ast cell degranulation by substance 
P. These data imrlicate a role for mast cell- derived TNFa in 
the regulation 0 the integrins a6fJ4 and a6fJl on LC. These 
findings may have important implications relevant to mech-
anisms for spatial localization of LC within the cutaneous 
compartments during immune responses. Key words: tumor 
necrosis factor, immunoelectron microscopy, substance P, 
cromolyn sodium. ] Invest DermatoI101:150-154, 1993 
TNFO' [5,6]. It is unclear whether mast cell TNFO' may also playa 
role in the induction and elici tation of contact hypersensitivity via 
effects on antigen-presenting cells. 
If endogenous molecules such as mast cell TNFO' can affect the 
ability of LC to traffic freely from epidermis to lymph nodes, then it 
is reasonable to explore the possible role of integrins in this process. 
Integrins expressed in the skin are thought to playa key role in 
tethering cells to constituents of the extracellular matrix [7] . . For 
example, the 0'6{34 heterodimer is believed to anchor basal kerati-
nocytes to larninin within the underlying basement membrane zone 
[8,9]' and the 0'6{31 integrin on mast cells [10]' melanocytes [11], 
macrophages [12], and endothelial cel ls [13], interacting with its 
ligand, laminin, appears to affect the microanatomical localization 
of these cells. Although initial immunohistochemical attempts to 
document integrins on LC have failed [14], application of more 
sensitive immunoultrastructuraJ assays has demonstrated at least 
small quantities of 0'4, 0'5, 0'6, and {31 integrin subunits on the 
membranes of normal LC [15,16]. 
In a recent study, we demonstrated that mast cel l degranulation 
can alter the expression of 0'6{31 and 0'6{34 integrins on epidermal 
keratinocytes in a TN Fa-dependent fashion.' Based upon this ob-
servation, and the fragmentary evidence tbat endogenously released 
TNFO' may influence LC function or mobility, we asked whether 
mast cell products are capable of affecting LC expression of these 
adhesion molecules, potentially affecting their migratory abili ty 
during immune responses involving mast cell degranulation. 
MATERIALS AND METHODS 
Foreskin Organ Culture Normal neonatal human foreskin (Caucasian) 
was obtained from elective surgical ci rcumcisions and explants were pre-
pared according to techniques previously described in detail [17]. Briefly, 
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small explants (3 mm X 3 mm) were cut from a fres h specimen, rinsed in 
culture medium at 4DC, and placed dermal side down in 34-mm wells in 
RPMI 1640 media (JRH Biosciences, Lenexa, KS) containing 10% (v/v) 
feta l calf serum, penicillin (100 I.U ./ml) , streptomycin (100 jig/ml) , and 
2 rnM L-glutamine. Explant viability in this system has been assessed by 
ul trastructure and the ability to upregulate intercellular adhesion molecule-1 
(rCAM-1) on keratinocytes afte r a 24-h incubation with recombinant inter-
fero n-y [1 8]. Explants were incubated for 0, 1,6, and 24 h at 37 DC in 5% 
CO2 /95% air, with and without mediators. Samples were harvested after 
culture, washed in phosphate-buffered saline, and frozen in liquid nitrogen 
in OCT compound (Miles Laboratories, Naperville, IL) . Three ex plants 
were cuI tu red fo r each condition per experiment, and seven independent 
experiments were conducted. 
Mediators Mast cel l degranulation was achieved by a 45-minute incuba-
tion of explants with substance P (Sigma Chemical Co., St. Louis, MO) at a 
finaJ concentration of5 X 10- 4 M or morph ine sulfate (Wyeth Laboratories, 
Inc., Philadel phia, PAl at a final concentration of 5 mM. Previous studies 
have demonstrated that this time course and dosage maximally degranulate 
mast cells as assessed by ultrastructure and intensity of E-selectin [formerly 
endothelial-leukocy te adhesion molecule 1 {ELAM-l)J induction on dermal 
post-capillary venules [1 7]. Explan ts were then returned to medium alone 
for the remainder of the culmre period. Other explants were incubated with 
recombinant human TNFa at final concentrations of 10, 100, and 1000 
U /ml (R & D Systems, Minneapolis, MN). In addition, we compared a short , 
initia l incubation (45 min) using these doses, followed by 24 h ofTNF-free 
culture, with continuous TNF incubation for 24 h. The highest dose used, 
1000 U / ml , has previously been shown in this model to induce E-selectin in 
the absence of toxicity as evidenced by ultrastructural damage or biosyn-
the tic alterations to target endothelial cells [1 8J. Blocking experiments were 
carried out by pre- incubating foreskin explants for 1 h in the mast cell 
inh ibitor cromolyn sodium (Sigma Chemical Co.) at a final concentration of 
1 mg/ml (1.95 mM) or anti-TNFa polyclonal antiserum (Genzyme, Bos-
ron, MA) at a final concentration of 105 U/ ml prior to the addition of mast 
cell secretagogue, substance P, or morphine sulfate. This concentration of 
cromolyn sodium has previously been shown to abrogate the induction of 
E-selectin on superficial dermal post-capillary venu les that occurs 6 h after 
the release of mast cel l-derived TNFa in skin explants [1 7J. 
Antibodies The monoclonal antibody GoH3 (AMAC, Inc., W estbrook, 
ME), w hich recognizes the murine a6 integrin subunit and has been shown 
to cross-react with human tissue [1 9]. was used at a dilution of 1: 200 fo r 
immunohistochemical detection of the a6 integrin subunit in foreskin ex-
plants. An isotype-matched rat myeloma IgG2a (Zymed Laboratories, San 
Francisco, CAl was used as a control at a dilution of 1 : 200. A monoclonal 
an tibody to the human /14 integrin subunit, clone 439-9B, was generously 
provided by S. J. Kennel, Oak Ridge National Laboratory, Oak Ridge, TN, 
and was used at a dilution of 1: 100. LCs were identified by the specific 
monoclonal antibody anti-leu 6 (CDl a; Becton Dickinson Ill1munocytoll1-
etry Systems, Mountain View, CAl [20,2 1J at a dilution of 1: 50. A mono-
clonal antibody to the human /11 integrin subunit, clone P4C l 0, was kindly 
provided by E. A. W ayner, University of Minnesota, Minneapolis, MN, and 
was used at a di lution of 1 : 10. Mast ce ll degranulation was confirmed by 
immunohistochemistry 1 h after addition of mast cell secretagogue using 
polyclonal antibodies to the serine protease chymase, which is specifica lly 
found in connective tissue mast ce ll granules [22]. 
Immunohistochemistry Cryostat sections were cut at 6 jim , air-d ried 
fo r 30 min, and fixed in cold acetone for 10 min prior to incubat ion with 
primary antibodies or appropriate irrelevanr controls [1 7]. In single-labeling 
experiments, an avidin-biotin-horseradish peroxidase complex (ABC) pro-
cedure was employed. Briefly, biotinylated, species-specific second-layer 
reagents were applied, followed by ABC (Vector Laboratories, Burlingame, 
CAl using 3,3' -diaminobenzidine (DAB) as a chromogenic substrate , as 
previously deta il ed [23]. Double-labeling experiments were performed 
using immunofluorescence techniques, as previously described [10]. For 
specific labeling of LC, affiniry-purified species-specific fluorescein 
isothiocyanate-conjugated second-layer antibody (Accurate Chemical & 
Scientific Corporation, Westbury, NY) was used. After incubations with 
primary antibody and biotinylated secondary reagents, Texas red -
conjugated streptavidin (Amersham Corporation, Arlington Heights, IL) 
was added as a third-layer reagent to identify areas of a6 immunoreactiviry 
in tissue sections. In this manner, labe ling of LC (green fluorochrome) and 
a6-posi tive cells (red fluorochrome) was achieved. Controls were used to 
demonstrate absence of non-specific LC stai ning by first-, second- , or third-
layer reagents. Immunofluorescence was examined using an MRC-600 
Confocal Imaging System (BioRad Microscience, London, England) cou-
pled with an epifluorescence refl ection research microscope. 
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Immunoclectron Microscopy The presence of isolated, a6-positive, 
mid-epidermal ce lls with ultrastructural characteristics ofLC was confirmed 
by immunoelectron microscopy, a tech nique that has been previously de-
scribed [24]. To summarize, experimental foreskin explants were harvested 
after 24 h in culmre and placed in Nakane's fixative for 2 h at 4DC, subse-
quently washed extensively with 0.05 M sodium phosphate, pH 7.2, con-
taining 7% sucrose, and then snap-frozen in OCT compound. Immunohis-
tochemistry using the ABC method as described above was performed on 
cryostat sections. After development with DAB, sections were fixed in 2% 
glutara ldehyde in 0.1 M phosphate buffer overnight at 4 DC and processed 
for transmission electron microscopy as described previously [17,24]. U l-
trathin sections were cut and viewed with and without uranyl acetate stain-
ing with a Hitachi H-7000 electron microscope. 
RESULTS 
Foreskin expl ants cultured for 24 h showed a norma l pattern of 
reactivi ty fo r the a6 and /34 integrin subunits, with reaction product 
predominantly confined to a thin , uniform, linear zone along the 
dermal-epidermal junction (Fig 1A ). The /11 pattern was also nor-
mal, and was expressed by membranes of basal and immediately 
suprabasal keratinocytes in confluence. Isolated, mid-epidermal 
cells developed reactivity for a6 (Fig IB, C), and to a lesser degree 
for /34 (Fig IB, upper iI/set) and /31 (Fig IB, lower illset) by 24 h after 
mast cell degranul ation consequent to morphine sul fate (Fig IB) or 
substance P (Fig lC). The pattern of a6 reactivity on mid-epidermal 
cells w as foca lly clustered , with 3 - 5 positive cells separated by 
unreactive zones (Fig 1 C). M ast cell degranulation was confirmed 
by immunoloca liza tion of the granule pro tease, chym ase, (Fig ID, 
iflSet) as previously described [6]. Pre-incubation of explants with 
the mast cell inhibitor cromolyn sodium [17] (Fig ID) , or with 
blocking antiserum to TN Fa (Fig I E ) [5,17]' prior to addition of 
mast cell secretagogue, abrogated the ability to induce a6 expres-
sion on mid-epidermal cells. Addition of recombinant T NFa to 
naive explants resulted in a6-positive mid-epidermal cells in a pat-
tern identical to that produced by mas t cell degranulation (Fig IF) . 
Of all doses and conditions tested, we found that a 45-min pulse of 
1000 U / ml TNFa (Fig IF) produces this effect most profoundly. 
Moreover, the integrity of the basal cell layer was dramatically 
improved by this shorter TNF incubation period. The possibility 
that cromolyn mig ht act by blocking the ability of TN Fa to affect 
Langerhans cells was tested by adding the recombinant cytokine to 
explants that were pre-incubated w ith cromolyn sodium. Cromo-
Iyn failed to inhibit th e abili ty of TN Fa to upregulate a6 integrins 
on Lan gerh ans cells (data not shown) . 
We identified a6-positive mid-epidermal cells as CDla-positive 
cells by dual immunofluorescence ass isted by confocal lase r scan-
ning microscopy (Fig 2A,B). a6 reactivity was primarily confined 
to cell bodies, an observation further confirmed by iml11unoelectron 
nl.icroscopy (Fig 2C) . These a6-positive cells failed to express tono-
filaments or desmosomes, and disp layed a dendritic contour consist-
ent w ith LC, although Birbeck granules were not encountered. 
Conventional transmission electron microscopy, however, revealed 
that all CD la-positive LC had lost th e ability to express these or-
ga nell es by 24 h after culture (in accord with previous observations 
[25]) , the time point at which a6 inductio n was observed . 
DISC USSION 
The data presented in this study suggest that a6 integrins are upreg-
ulated on the surface of epidermal LC subsequent to experimental 
mast cell degranulat ion. T he ability to inhibi t this effect using 
blocking antiserum to TNFa and to duplica te this finding by addi-
tion of the recombinant cyto kine to cultured explants su ggests a 
central role for endogenously-released TNFa in the regulation of 
expression of a6 integrins by LC. Recently, human dermal mast 
cells have been shown to syn thesize T N Fa and to release upon 
secretion sizeable stores of t h is cytokine from th eir cytoplasmic 
granules [5]. Mast cell degranulation results in local release of 
TNFa [6] and induction of pro-inflammatory biologic effects, such 
as upregulation of endo thelial ad hes ion molecul es for circu lating 
leukocytes [5,17]. W e cannot exclude the possibility that TNFa 
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Figure 1. Immunohistochemical staining for a6 integrin subunit in human foreskin before and after mast cell degranulation. In normal skin before culture 
and 24 h after culture, a6 is restricted to the inferior pole of basal kcratinocytes, forming linear reactivity along the dermal-epidermal junction (A) . Faint 
staining of basa l cell membranes may be observed 24 h after culture. Endothelial cells also demonstrate reactivity along the basement membrane. T wenty-four 
hours aftcr mast cell degranulation by secretagogues morphine sulfate (B) or substance P (C), solitary, dendriti c, mid-epidermal ce lls (indicated by arrows) 
become a6 positive. Insets in B demonstrate isolated , mid-epidermal cells (indicated by arrows) that stain positively fo r the p4 (lIpper illSet) and P1 (lower illset) 
integrin subunits. Pre-incubation of explants with the mast ccll inhibitor cromolyn sodium (D) or pre-incubation with polyclonal antibodies to TNFa (E) 
prior to induction of mast cell secretion with substance P, abrogated a6 upregul ation on mid-epidermal cells. IlISets in D show immunoreactivi ty fo r the mast 
cell - derived proteinase, chymase, which is weak 1 h after the addition of substance P (left ill set) , but strongly positive in analogous explants pre- incubated in 
cromolyn sodium (right inset) . Incubation of explants with recombinant TNFa for 45 min (F) reproduced at 24 h the pattern of a6 induction observed at this 
same timepoint after mast cell degranulation (arrows, a 6-pos itive Le) . Scale bar, 100 11m. ..... 
produced by keratinocytes [26] or dermal monocytes/ macrophages 
contributes to the induction of a6 integrins on LC after mast cell 
degranulation. However, the association with stimulation and inhi-
bition of experimental mast cell degranulation documented in this 
study suggests that the secretory products of mast cells are capable of. 
directl y or indirectly modulating the expression of epidermal LC 
integrins. W e also cannot exclude the possibility that mediators 
other than TNFa may have a contributing role. For example, mast 
cell chymase has been shown to activate interleukin 1/3 [27] , and 
thus TNFa is not the only cytokine pathway potentially stimulated 
when mast ce lls degranulate. The idea of mast cell participation in 
a6 induction is supported further by rece nt observations that upreg-
ulation of a6 and other integrins in the epidermis occurs in the 
settings of wound healing [28] and inflammatory dermatitis [29], 
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Figure 2. Identification of co-expression of CO 1 a and a6 integrin by mid-
epidermal cells after mast cell degranulation. By double immunofluores-
cence labeling as analyzed by confocal laser scanning microscopy, solitary 
COla-positive cells (A, green fluorescence) and a6-positive cells (B, red 
fluorescence) proved to be congruent populations. Scale bar, 10 t/lll . Immun-
oelectron microscopy of the same tissue (C) demonstrated reactivity for a6 
along the plasma membrane of the cell body of mid-epidermal cells. These 
cel ls were dendriti c, lacked desmosomes and tonofilaments, and like Lan-
gerhans ce lls in contrOl explants cultured for 24 h and examined by conven-
tional transmission electron microscopy, lacked Birbeck granules. Keratino-
cyte nuclei are indica ted by Nu. Scale bar, 1 f1.m. 
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two conditions that may involve mast cell degranulation ill villo as a 
prominent feature [24,30]. 
The upregulation of a6 integrins on Langerhans cells occurs 
focally within the epidermal layer. W e have been unable to identify 
a structural explanation (e. g., clustered localization of underlying 
mast cells), or an explanation based upon differential or uneven 
mediator permeabi liry in our explants. With respect to this issue, it 
may be significant that heterogeneity among Langerhans cells has 
been reported in humans with regard to HLA-DR expression [31 ]. 
The possibility that Langerhans cells may be differentially sensitive 
to factors responsible for a6 induction remains to be explored. 
The funct ional significance of integrin expression by LC remains 
speculative. Small quantities of membrane-associated integrins have 
been documented on normal human LC lISing immunoultrastruc-
tural approaches [15] . It has been reasoned that these molecules may 
enhance the abiliry of LC to interact with extracellular matrix pro-
teins during migration [32]. An alternative hypothesis is that inte-
grins may facilitate cell-cell adhesion [33] and therefore could con-
tribute to the normal localization of LC within the middle stratum 
of the epidermis. Additional studies of experimental contact hyper-
sensitiviry reactions in humans indicate that mast cell products are 
not significantly released during sensitization [6,24], a time when 
LC migration to draining lymph nodes occurs [2]. On the other 
hand, mast cell degranulation is an early event in challenge reactions 
[24] , when relatively stationary epidermal LC present antigens lo-
cally to small numbers of sensitized memory T cells that immigrate 
from the blood [2,34,35]. It is intriguing to speculate, therefore, 
that in addition to the induction of endothelial-leukocyte adhesion 
molecules that promote memory T-cell influx [5,6,35]' TN Fa re-
leased by mast cells and other skin cells may fix LC within the 
epidermal compartment via integrin induction, producing a situa-
tion conducive to antigen presentation to locally-recruited lympho-
cytes. 
Studies are now indicated to elucidate the fu ll repertoire of skin 
cytokines capable of regulating integrins on skin immune cells such 
as LC. Furthermore, it must be ascertained whether experimental 
manipulation of LC integrin expression by pro-inflammatory cyto-
kines influences LC binding and movement, and whether such ef-
fects alter the abi liry to elicit sensitization and challenge reactions. 
Streilein [4] has demonstrated in mice that intradermal injection of 
TNFa inhibits the abiliry to induce contact sensitization, and that 
immobilization ofLC within the epidermis m'ay be partly responsi-
ble for this effect. This observation is consonant with the findings of 
the present study and also raises the possibiliry that TNFa-induced 
alterations in LC integrin expression may have functional signifi-
cance with important therapeutic implications . 
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ANNOUNCEMENT 
The Westwood Conference on C linical Dermatology will be held October 16-20,1993 at 
Grove Park Inn Resort, Asheville, North Caro lina. 
The Westwood Winter Skin Seminar will be held January 30 to February 4, 1994 at The 
Westin Resort, Vail, Colorado. 
For furt her information, please contact Westwood-Squibb Pharmaceuticals, Professiona l 
Relations, 100 Forest Avenue, Buffalo, NY 14213. (71 6) 887-3678; (716) 887-3604 (Fax) . 
